Xtx Topco LTD Surface Oncology, Inc. Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.61 - $1.03 $88,880 - $150,076	-145,705 Reduced 79.37%	37,874 $26,000
Q4 2022 Feb 14, 2023	SELL	$0.62 - $1.21 $113,238 - $220,996	-182,642 Reduced 49.87%	183,579 $150,000
Q3 2022 Nov 14, 2022	BUY	$1.05 - $2.1 $255,957 - $511,914	243,769 Added 199.07%	366,221 $381,000
Q2 2022 Aug 15, 2022	BUY	$1.42 - $3.15 $154,314 - $342,316	108,672 Added 788.62%	122,452 $201,000
Q1 2022 May 13, 2022	SELL	$2.65 - $5.08 $12,166 - $23,322	-4,591 Reduced 24.99%	13,780 $41,000
Q4 2021 Feb 11, 2022	BUY	$4.73 - $7.9 $86,894 - $145,130	18,371 New	18,371 $88,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.